Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2236 to 2250 of 7681 results

  1. Tislelizumab with platinum-based chemotherapy and etoposide for untreated extensive-stage small-cell lung cancer [ID6158]

    Awaiting development [GID-TA11094] Expected publication date: TBC

  2. Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy [ID6161]

    Awaiting development [GID-TA11099] Expected publication date: TBC

  3. Tislelizumab in combination for untreated advanced non-small-cell lung cancer [ID6162]

    Awaiting development [GID-TA11101] Expected publication date: TBC

  4. Accuro handheld ultrasound device for locating intervertebral space for administration of spinal anaesthesia

      Status ...

  5. Insertion of a Catheter based intravascular microaxial blood pump for acute heart failure

    Awaiting development [GID-IPG10404] Expected publication date: TBC

  6. In-situ Normothermic Regional Perfusion system for DCD donors

    Awaiting development [GID-IPG10405] Expected publication date: TBC

  7. Insertion of neo-chordae into the beating heart for mitral regurgitation

    In development [GID-IPG10216] Expected publication date: TBC

  8. High linear energy transfer radiation for carbon ion beam therapy

    Register an interest in this interventional procedure   ...

  9. Differential Target Multiplexed Spinal Cord Stimulation (MT742)

      Status ...

  10. Children and young people with disabilities and severe complex needs: integrated health and social care support

    Awaiting development [GID-QS10146] Expected publication date: TBC

  11. Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care

    Awaiting development [GID-QS10144] Expected publication date: TBC

  12. Pelvic floor dysfunction

    Awaiting development [GID-QS10129] Expected publication date: TBC

  13. Vibostolimab–pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID6382]

    Awaiting development [GID-TA11466] Expected publication date: TBC

  14. Osteoporosis

    Awaiting development [GID-QS10188] Expected publication date: TBC